Repurposing MS immunotherapies for CIDP and other autoimmune neuropathies: unfulfilled promise or efficient strategy?

Despite advances in the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) and other common autoimmune neuropathies (AN), still-many patients with these diseases do not respond satisfactorily to the available treatments. Repurposing of disease-modifying therapies (DMTs) fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kohle, Felix, Dalakas, Marinos C., Lehmann, Helmar C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810996/
https://www.ncbi.nlm.nih.gov/pubmed/36620728
http://dx.doi.org/10.1177/17562864221137129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810996/
https://www.ncbi.nlm.nih.gov/pubmed/36620728
http://dx.doi.org/10.1177/17562864221137129

Ejemplares similares